The epidemiology of multifood allergy in the United States

Warren, Christopher; Aktaş, Ozge Nur; Manalo, Lorenzo; Bartell, Tami R.; Gupta, Ruchi S.

doi:10.1016/j.anai.2022.12.031

Cited by 26 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 In the USA, a recent population-based study showed that 40-48% of children and adults with FA had an allergy to multiple foods. 4 In Europe, the point prevalence of self-reported FA was 13.1% and higher than previous estimates. 3 Similar trends were seen in the New Zealand, and Australia.…”

Section: Introductionmentioning

confidence: 63%

Risk Factors for Severe Seafood Allergy Among Adults in an Urban City in Vietnam

Trinh,

Duong,

Pham

et al. 2024

JAA

View full text Add to dashboard Cite

Increasing seafood consumption is associated with more frequent reports of food allergy. Little is known about seafood allergy (SFA) among adults in Vietnam. We investigated the characteristics of individuals with SFA and the risk factors for severe SFA. Patients and methods: A cross-sectional, web-based survey was conducted among individuals aged ≥ 18 years from universities in Ho Chi Minh City (Vietnam) between December 2021 and July 2022. The survey was based on a structured, validated questionnaire related to FA. Strict definitions of "convincing allergy" were used. Multivariate analysis was used to estimate the risk factors for severe SFA after adjusting for covariates. Data were analyzed using JASP (v.0.16.3) and SPSS (v.22.0). Results: Totally, 1038 out of 2137 (48.57%) individuals completed the questionnaire, of whom 285 (27.46%) had reported SFA. Convincing SFA accounted for 20.13% (209/1038) of the cases, with convincing shellfish allergy being more common than fish allergy. Participants with comorbid shellfish and fish allergy had higher prevalence of atopic dermatitis, peanut/nut allergy, other food allergy, and cutaneous and upper airway symptoms compared to participants with shellfish allergy (p < 0.05). The spectrum of reactive seafood was diverse and characterized by local species. The age of symptom onset was most commonly during late childhood and adolescence, with most reactions persisting into adulthood. A history of anaphylaxis, comorbid peanut, and tree nut allergy, and ≥3 allergens were associated with severe SFA. Conclusion: Features of causative, coexisting seafood allergy, and risk factors for severe SFA were demonstrated, which can provide a reference for future studies.

show abstract

Section: Introductionmentioning

confidence: 63%

Risk Factors for Severe Seafood Allergy Among Adults in an Urban City in Vietnam

Trinh,

Duong,

Pham

et al. 2024

JAA

View full text Add to dashboard Cite

show abstract

“…A recent US population-based study reported that, among children with food allergies, 40% had multiple food allergies, meaning that they were allergic to at least 2 different foods. 55) Research on multifood OIT is limited, and studies to date often involved the combined use of omalizumab. [41][42][43] The OUtMATCH study is a phase III multicenter randomized double-blind placebo-controlled study that awaits the results of both omalizumab monotherapy and omalizumab-facilitated OIT for multifood allergy.…”

Section: A C C E P T E D a R T I C L Ementioning

confidence: 99%

Recent advances in food allergen immunotherapy

Jeon,

Kim

2023

Clin Exp Pediatr

View full text Add to dashboard Cite

Food allergies can pose significant risks and profoundly impact the quality of life of children and their families, making them a major public health concern. Allergen avoidance has been the traditional mainstay of treatment; however, recent research has focused on various approaches to food allergen immunotherapy. This review summarizes the recent advancements in oral, sublingual, and epicutaneous immunotherapies, highlighting their respective advantages and disadvantages. The ultimate goal of food allergen immunotherapy is to maximize efficacy while minimizing risks, leading to the exploration of strategies such as low-dose immunotherapy and the use of biologics. When selecting candidates for immunotherapy among patients with food allergies, factors such as allergen characteristics, the likelihood of natural resolution, age, symptom severity, and impact on quality of life require consideration, and an individualized approach should be adopted to determine the most suitable treatment method.

show abstract